Navigation Links
Ocean Tomo Study Ranks Top 25 Most Inventive Illinois Companies in 2011 for Crain’s Chicago Business
Date:6/25/2012

Chicago, IL (PRWEB) June 25, 2012

Ocean Tomo, LLC, the Chicago-based Intellectual Capital Merchant Banc™ firm, announced the results of a proprietary study performed for Crain’s Chicago Business. The study, which ranks the 25 Illinois companies with the highest rated patent portfolios issued in 2011, was performed using the Ocean Tomo PatentRatings® system. This proprietary web-based platform (U.S. Patent No. 6,556,992) calculated a statistical measure of the relative quality of patents issued in 2011 to Illinois companies. Ranking companies based on this statistical quality metric is a proven means to identify future industry leaders. “The Ocean Tomo PatentRatings® study conducted for Crain’s Chicago Business suggests that Illinois has a broad diversity of established and emerging technology driven companies” explains James E. Malackowski, President and CEO of Ocean Tomo.

“Patents are one of the most reliable and critical indicators of a company’s strategic intent,” says Malackowski. “Furthermore, companies holding valuable patents in sufficient quantity are likely to shape industry direction and outperform their peers with respect to equity returns.” Malackowski cites the strong performance of the Ocean Tomo 300® Patent Index (NYSE Euronext: OTPAT) as support for the firm’s conclusions. "The ultimate value of a patent portfolio is not the rating or even licensing income; both are indirect effects” notes Malackowski. “The ultimate measure of value is the portfolio's effect on earnings and stock price. Our rating system has proven to be a forward looking indication of stock value with demonstrated out-performance as compared to the S&P 500 over a sustained period of time.”

To view the study methodology or see the expanded listing of the top 75 Illinois companies, visit http://www.OceanTomo.com/TopIllinoisCompanies.

About Ocean Tomo PatentRatings® Software System

Ocean Tomo PatentRatings® software system is the first proven, market-validated software platform for objectively assessing patent quality, relative valuation, and competitive trends for patents, patent portfolios, companies, and technology sectors. The PatentRatings® system provides customizable data solutions and delivers actionable data to companies, investors, bankers, attorneys and other intellectual property professionals and decision makers. The Ocean Tomo PatentRatings® system provides an unparalleled understanding of patent quality, technology implications, and strategic insight. Visit (http://www.OceanTomo.com/Ratings) for more information about data subscriptions or individual reports.

About Ocean Tomo
Established in 2003, Ocean Tomo, LLC, is the Intellectual Capital Merchant Banc™ firm. The company provides financial products and services related to Intellectual Property, including expert testimony, valuation, strategy, research, ratings, investments, risk management and transactions. Ocean Tomo assists clients – corporations, law firms, governments and institutional investors – in realizing Intellectual Capital Equity® value broadly defined.
Headquartered in Chicago, Ocean Tomo has offices in Greenwich, Houston, Orange County and San Francisco. Subsidiaries of Ocean Tomo include: Ocean Tomo Risk Management, LLC; Ocean Tomo Asset Management, LLC; OTI Data Networks, LLC; Patent Marking, LLC; and Ocean Tomo Capital, LLC – publisher of the Ocean Tomo 300® Patent Index family. Ocean Tomo is the founder of the Intellectual Property Exchange International (IPXI), Inc. as well as the exclusive licensee and distributor of the PatentRatings® system. For further information, visit http://www.OceanTomo.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9638957.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. NSF CAREER grants support ocean energy, microforming, computer planning
2. Jellyfish inspires latest ocean-powered robot
3. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
4. Positive Clinical Study Results for BSPs HyperQ Technology
5. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
6. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
7. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
8. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
9. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
10. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
11. Singapore scientists lead human embryonic stem cell study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
(Date:3/22/2017)... March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), ... Center (RGC), U.K. Biobank and GSK to generate genetic sequence ... resource. The initiative will enable researchers to gain valuable insights ... a wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
(Date:3/1/2017)... -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics ... has resigned, effective March 3, 2017, as co-Chief ... Treasurer of Aware citing a desire to retire.  Mr. ... the Board of Directors of Aware. ... co-President, General Counsel has been named Chief Executive Officer, ...
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
Breaking Biology News(10 mins):